Clinical Trial Update: Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 mass-balance pharmacokinetics study of [14C]HMPL-523 in healthy adult male Chinese subjects completed, sponsored by Hutchmed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• HMPL-523

Snippet

Sponsor: Hutchmed | Conditions: Imumune Thrombocytopenia(ITP) Human Mass Balance | Phase 1 | Status: COMPLETED